Some important comparative parameters between Patients with Chronic Renal Failure and Patients with Diabetic Nephropathy in Erbil
AbstractBackground and Objectives: Patients with chronic renal failure and diabetic nephropathy reveals biochemical changes .This study aim to investigate the differences of some impor-tant biochemical changes in these two groups of patients in comparison with normal con-trols. Methods: (80) patients were selected with different Renal disease complications. A control group of (30) healthy,18 males and 12 females were included in this study. Patients were divided into two groups the first group with chronic renal failure, include (40) patients,(25) male and (15) female ; the second group with diabetic �nephropathy , include ( 40) pa-tients,(25) male, and (15) female. Determination of the biochemical compound level as creatinine ,urea ,uric acid ,total protein (T.P) , albumin ,total cholesterol (TC), triglyceride(TG), low density lipo-protein (LDH-c) ,high density lipoprotein (HDL-c) , and LDL-c/HDL-c ratio. Results: Patients with chronic renal failure showed increasing levels of (creatinine, urea, -uric acid ) in their serum, and lower levels of (total protein, albumin). Mild increase in lev-els of (TC, LDL-c), while great increased level of triglyceride were recorded, also a great decline in the level of HDL-c was found, which indicate a high risk factor and moderate in-crease in (LDL-c/HDL-c) ratio .Patients with diabetic nephropathy showed slight increase in the levels of (creatinine, urea, uric acid ), however still lower than that in chronic renal fail-ure group. Also they showed decreased levels of (total protein, albumin) ,but still lower than in chronic renal failure and Increased level of ( TC,TG, LDL-C, LDL-c/HDL-c) which were greater than the increase in chronic renal failure .Also decrease in the level of HDL-c, but still less than that in chronic renal failure. Conclusions: Patients with chronic renal failure or with diabetic nephropathy showed sig-nificant increase in the levels of creatinine, urea, and uric acid; and decreased levels of al-bumin and total protein. Both group of patients showed variation in their cholesterol, LDL-c, triglyceride, and LDL/HDL-c ratio.
Dirks JH, de Zeeuw D, Agarwal SK. Prevention f chronic kidney and vascular Disease: Toward global health equity- The Bellagi Declara-tion.Kidney Int. 2005; 68: SI-S6.
Ozsoy RC, Kastelein JJ, Arisz L, Koopman MG. Atorvastatin and the dyslipidemia Of early renal failure .Atherosclerosis 2003; 166:187-194.
Snideman AD, Scantlebury T, Cianflone K . Hy-pertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus .An intern Med 2001; 135:447-459.
Coonrod BA, Ellis D, Bicker DJ.Predictors of mi-croalbuminuria in individuals with IDDM. Diabetes care 1993; 16:1376-1383.
Kasiske BL, Donnell MP ,Cleary MP,Kean WF.Treatment of hyperlipidemia reduces glome-rular injury in obese zucker rats .Kidney Int, 1988;333:667-672.
Watts GF, Powrie JK, Brien SF, Shaw KM.Apolipoprotein B independently predicts pro-gression of very �low level albuminuria in insulin-dependent diabetes mellitus. Metabolism 1996; 45:1101-1107.
Majumdar A and Wheeler DC.Lipid abnormalities in renal disease .J R Soc Med 2000;178-182.
McLeod R, Reeve CE, and Frohlich J .Plasma lipoprotein and lecithin: cholesterol acyltrans-ferase distribution in patients with dialysis.Kidney Int. 1984; 25:683-688.
Liang K, Oveisi F, and Vaziri ND. Down regulation of hepatic high-density lipoprotein receptor,SR-BI in nephritic syndrome.Kidney Int. 1999; 56:621-626.
Alemzadeh R, Wyatt DT. Diabetes mellitus in chidren. Nelson Textbook of pediatrics. 18th ed. Philadelphia:Saunder. 2008; 2404-2431.
Keyiro, S.Shiro, J and Bozh, A,J.Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int. 1996; 49:488
Miguel, H. S. and Lapuz, M.D.,J.Diabetic Neph-ropathy : Diagnosis,prevention,and Treatment. Medical clinics of North America. 1997;81(3),
Majumdar A and wheeler DC.Lipid abnormalities in renal disease.JR soc.Med 2000;93:178-182...
Almadtae, .M.Assesment of function kidney from chronic renal failure, thesis MSc Baghdad Uni-versity ,College of Medicine 1988;75-92 .
Rutkowski B, Szolkiewicz M, Korczynsk J. The role of lipogenesis in the development of uremic hyperlipidemia. Am J Kidney Dis.2003; :41:84-88.
Al Hadithe ,A.H ., Biochemical study of Broncho-genic carcinoma .thesis M.Sc ,Baghdad Univer-sity ,College of Pharmacy .1992.(94-104).
Mcleod R, Reeve CE, and Frohlich J. Plasma lipoproteins and lecithin :Cholestrol acyltrans-ferase distribution in patients on dialysiss. Kidney Int 1995; 25:683-688.
Sultan ,T.R., Serum lipid profile in chronic renal failure . Thesis, M.SC, Baghdad University , Col-lege of Medicine .1986.
Shoji T, Nishizawa Y , Nishitani H. Impaired me-tabolism of high density lipoprotein in uremic patients.Kidney Int. 1999; 41: 1653-1661.
SZolkiewicz M, Nieweglowski T, Korczynska J. Upregulation of fatty acid synthase gene expres-sion in experimental chronic renal failure. Me-tabolism. 2000;51:1605-1610.
Vaziri N.Dyslipidemia of chronic renal failure:the nature,mechanisms,and Potential conse-quences .Am J Renal physiol 2005;290:F262-F272.
Attman PO, Samuelsson O, and Alaupovic P.Lipoprotein metabolism and renal failure.Am J Kidney Dis1999; 21:573-592.
Shoji,T., Nishizawa, Y.,Kawagishi, T., and Tamaka ,M., J. Atherosclerosis 2001 ; 13 (2):229.
Craven P A, Studer R K, Negrete H. Protein in diabetic nephropathy. J Diabetes complications 1995;9: 241-245.
Genest J Jr, Marcil M, and Yu L.High lipopro-teins in health and in disease.J Investig Med 1999; 47:31-42.
Hakim RM and Lazarus JM. Biochemical pa-rameters in chronic renal failure. Am J Kidney Dis 1998; 11(3): 238-247.
Ali J, Junita K, Vivian A. Diabetic nephropathy. Medical Clinics of North America 2004; volume 88.
Gall MA, Hougaard P,Borch-Johnsen K. Risk factors for development of incipient and overt diabetic nephropathy in patients with non insulin dependent diabetes mellitus .BMJ 1997;314:783-788.
Vaziri ND and Liang K. Down regulation of LDL and HDL in experimental nephrosis.Kidney Int . 1996;50: 887-893.
Caramori ML, Kim Y, Huang C. Cellular basis of diabetic nephropathy . Diabetes 2004;51:506-513.
Michael J.Fowler,MD . Complication of Diabe-tes.clinical diabetes.2008;26;77-82.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).